Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Ehrlich

Showing results (131-140 of 278) with videos related to

Pageof 28
Sort By:
Nature Methods|April 12, 2011
A parallel microfluidic flow cytometer for high-content screeningBrian K McKenna, James G Evans, Man Ching Cheung, et al.
Plos Computational Biology|January 10, 2013
Using molecular mechanics to predict bulk material properties of fibronectin fibersMark J Bradshaw, Man C Cheung, Daniel J Ehrlich, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 1, 1970
Altered myocardial lactic dehydrogenase isoenzymes in experimental cardiac hypertrophyB E Sobel, P D Henry, B J Ehrlich, et al.
The Australian and New Zealand Journal of Surgery|February 1, 1994
Urolithiasis in Australian aboriginal childrenC R Thambi Dorai, P A Dewan, H A Boucaut, et al.
Analytical Chemistry|September 6, 2008
Reaction-mapped quantitative multiplexed polymerase chain reaction on a microfluidic deviceJörn Ueberfeld, Brian McKenna, Ifat Rubin-Bejerano, et al.
American Heart Journal|March 1, 1997
Physiologic response of end-tidal carbon dioxide concentration to paced and induced tachycardias in human beings: basis for design of an automatic external physiologic defibrillatorT J Cohen, R Jadonath, B Goldner, et al.
Critical Care Medicine|February 6, 2004
Only activated protein C treatment and not protein C has demonstrated an improvement in survival in severe sepsisS Betty Yan, Jean-Francois Dhainaut, Hans Peter Schwarz, et al.
Mabs|January 5, 2010
How can we improve antibody-based cancer therapy?Li Yan, Paula J Ehrlich, Raymond Gibson, et al.
The Journal of Biological Chemistry|June 15, 1992
Mapping of binding sites for heparin, plasminogen activator inhibitor-1, and plasminogen to vitronectin's heparin-binding region reveals a novel vitronectin-dependent feedback mechanism for the control of plasmin formationC Kost, W Stüber, H J Ehrlich, et al.
The Journal of Biological Chemistry|June 5, 1991
Vitronectin governs the interaction between plasminogen activator inhibitor 1 and tissue-type plasminogen activatorJ Keijer, H J Ehrlich, M Linders, et al.
Pageof 28

Showing results (131-140 of 278) with videos related to

Sort By:
Pageof 28
Nature Methods|April 12, 2011
A parallel microfluidic flow cytometer for high-content screeningBrian K McKenna, James G Evans, Man Ching Cheung, et al.
Plos Computational Biology|January 10, 2013
Using molecular mechanics to predict bulk material properties of fibronectin fibersMark J Bradshaw, Man C Cheung, Daniel J Ehrlich, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 1, 1970
Altered myocardial lactic dehydrogenase isoenzymes in experimental cardiac hypertrophyB E Sobel, P D Henry, B J Ehrlich, et al.
The Australian and New Zealand Journal of Surgery|February 1, 1994
Urolithiasis in Australian aboriginal childrenC R Thambi Dorai, P A Dewan, H A Boucaut, et al.
Analytical Chemistry|September 6, 2008
Reaction-mapped quantitative multiplexed polymerase chain reaction on a microfluidic deviceJörn Ueberfeld, Brian McKenna, Ifat Rubin-Bejerano, et al.
American Heart Journal|March 1, 1997
Physiologic response of end-tidal carbon dioxide concentration to paced and induced tachycardias in human beings: basis for design of an automatic external physiologic defibrillatorT J Cohen, R Jadonath, B Goldner, et al.
Critical Care Medicine|February 6, 2004
Only activated protein C treatment and not protein C has demonstrated an improvement in survival in severe sepsisS Betty Yan, Jean-Francois Dhainaut, Hans Peter Schwarz, et al.
Mabs|January 5, 2010
How can we improve antibody-based cancer therapy?Li Yan, Paula J Ehrlich, Raymond Gibson, et al.
The Journal of Biological Chemistry|June 15, 1992
Mapping of binding sites for heparin, plasminogen activator inhibitor-1, and plasminogen to vitronectin's heparin-binding region reveals a novel vitronectin-dependent feedback mechanism for the control of plasmin formationC Kost, W Stüber, H J Ehrlich, et al.
The Journal of Biological Chemistry|June 5, 1991
Vitronectin governs the interaction between plasminogen activator inhibitor 1 and tissue-type plasminogen activatorJ Keijer, H J Ehrlich, M Linders, et al.
Pageof 28